A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients

Clinical trial NCT00202644 · COMPLETED

Trial details

NCT number: NCT00202644
Sponsor: Shire
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Thrombocythemia, Hemorrhagic

Start date: 2006-01-13
Primary completion: 2015-12-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.